WEBULL
News
TLPPF
7.79
NaN%
--
Telix Issues Over 2.5 Million Unquoted Share Appreciation Rights Under Incentive Plan
TipRanks · 16h ago
Telix Seeks ASX Quotation for Additional Ordinary Shares After Option Conversions
TipRanks · 16h ago
Weekly Report: what happened at TLPPF last week (1215-1219)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 2d ago
Telix Advances Precision Imaging Portfolio With Strong China Trial Data and FDA Progress
TipRanks · 2d ago
Telix Pharmaceuticals Facing Class Action after Cancer Claims Raise Investor Concerns
TipRanks · 5d ago
Citi Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)
TipRanks · 6d ago
Telix Advances ProstACT Global Phase 3 Prostate Cancer Study
TipRanks · 12/17 08:37
Weekly Report: what happened at TLPPF last week (1208-1212)?
Weekly Report · 12/15 09:36
Telix Pharmaceuticals (TLPPF) Gets a Hold from RBC Capital
TipRanks · 12/15 07:06
Telix Pharmaceuticals Updates Securities Dealing Policy
TipRanks · 12/14 22:18
Weekly Report: what happened at TLPPF last week (1201-1205)?
Weekly Report · 12/08 09:36
Telix Pharmaceuticals (TLPPF) Receives a Buy from Canaccord Genuity
TipRanks · 12/08 02:35
Telix Pharmaceuticals Advances Prostate Cancer Therapy with Phase 3 Trial Expansion
TipRanks · 12/07 22:37
Weekly Report: what happened at TLPPF last week (1124-1128)?
Weekly Report · 12/01 09:34
Citi Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)
TipRanks · 11/27 22:35
Weekly Report: what happened at TLPPF last week (1117-1121)?
Weekly Report · 11/24 09:36
Telix Pharmaceuticals (TLPPF) Receives a Buy from Morgan Stanley
TipRanks · 11/20 23:06
Weekly Report: what happened at TLPPF last week (1110-1114)?
Weekly Report · 11/17 09:37
Weekly Report: what happened at TLPPF last week (1103-1107)?
Weekly Report · 11/10 09:35
More
Webull provides a variety of real-time TLPPF stock news. You can receive the latest news about Telix Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TLPPF
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.